Balakumar Vijayakrishnan

850 total citations
20 papers, 591 citations indexed

About

Balakumar Vijayakrishnan is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Balakumar Vijayakrishnan has authored 20 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Balakumar Vijayakrishnan's work include Carbohydrate Chemistry and Synthesis (7 papers), HER2/EGFR in Cancer Research (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Balakumar Vijayakrishnan is often cited by papers focused on Carbohydrate Chemistry and Synthesis (7 papers), HER2/EGFR in Cancer Research (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Balakumar Vijayakrishnan collaborates with scholars based in United Kingdom, United States and Australia. Balakumar Vijayakrishnan's co-authors include Benjamin G. Davis, Julia R. Koeppe, Amirreza Faridmoayer, Michael Kowarik, Simon Chivers, Karin Havenith, Patrick H. van Berkel, Francesca Zammarchi, Ling Bing Kong and Jin Park and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Analytical Chemistry.

In The Last Decade

Balakumar Vijayakrishnan

20 papers receiving 583 citations

Peers

Countries citing papers authored by Balakumar Vijayakrishnan

Since Specialization

Citations

This map shows the geographic impact of Balakumar Vijayakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balakumar Vijayakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balakumar Vijayakrishnan more than expected).

Fields of papers citing papers by Balakumar Vijayakrishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Balakumar Vijayakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balakumar Vijayakrishnan. The network helps show where Balakumar Vijayakrishnan may publish in the future.

Co-authorship network of co-authors of Balakumar Vijayakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Balakumar Vijayakrishnan. A scholar is included among the top collaborators of Balakumar Vijayakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Balakumar Vijayakrishnan. Balakumar Vijayakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Extensive Biotransformation Profiling of AZD8205, an Anti-B7-H4 Antibody-Drug Conjugate, Elucidates Pathways Underlying Its Stability In Vivo 2024 ·Analytical Chemistry ·Yue Huang, (unknown), Jiaqi Yuan, (unknown), (unknown), Kathryn Ball, Balakumar Vijayakrishnan, Luke A. Masterson, Krista Kinneer, Nadia Luheshi, Meina Liang, Anton I. Rosenbaum	9
2	Abstract 5736: AZD9592: An EGFR-cMET bispecific antibody-drug conjugate (ADC) targeting key oncogenic drivers in non-small-cell lung cancer (NSCLC) and beyond 2023 ·Cancer Research ·Frank I. Comer, Yariv Mazor, Elaine M. Hurt, Chunning Yang, Ryan Fleming, (unknown), Balakumar Vijayakrishnan, (unknown), Ruoyan Chen, Edward Rosfjord, Nicolas Floc’h, Anton I. Rosenbaum, Yue Huang, Jiaqi Yuan, Kevin Beaumont, Lisa Godfrey, Lara McGrath, Fernanda I. Arnaldez, Puja Sapra	16
3	Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody–Drug Conjugate Efficacy and Toxicity 2022 ·Molecular Cancer Therapeutics ·Arnaud Tiberghien, Balakumar Vijayakrishnan, (unknown), (unknown), (unknown), John P. Bingham, Lauren Adams, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ravinder Tammali, Edward Rosfjord, (unknown), John A. Hartley, Philip W. Howard	3
4	Efficacy, Tolerability, and Pharmacokinetic Studies of Antibody–Drug Conjugates Containing a Low-Potency Pyrrolobenzodiazepine Dimer 2022 ·Molecular Cancer Therapeutics ·Stephen J. Gregson, (unknown), Neki V. Patel, (unknown), Balakumar Vijayakrishnan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lauren Adams, Conor S. Barry, Kathryn Ball, Luke A. Masterson, Mary McFarlane, John A. Hartley, Philip W. Howard	4
5	Simultaneous monitoring of multiple attributes of pyrrolobenzodiazepine antibody-drug conjugates by size exclusion chromatography – high resolution mass spectrometry 2021 ·Journal of Pharmaceutical and Biomedical Analysis ·Florian Füssl, Conor S. Barry, (unknown), (unknown), Balakumar Vijayakrishnan, (unknown), (unknown), Philip W. Howard, Jonathan Bones	7
6	CD25-targeted antibody–drug conjugate depletes regulatory T cells and eliminates established syngeneic tumors via antitumor immunity 2020 ·Journal for ImmunoTherapy of Cancer ·Francesca Zammarchi, Karin Havenith, (unknown), Balakumar Vijayakrishnan, Simon Chivers, Patrick H. van Berkel	55
7	A Reactive Antibody Platform for One-Step Production of Antibody–Drug Conjugates through a Diels–Alder Reaction with Maleimide 2019 ·Bioconjugate Chemistry ·André H. St. Amant, Feng‐Ying Huang, (unknown), (unknown), (unknown), Shenlan Mao, Christine Fazenbaker, Haihong Zhong, Jay Harper, Wenshu Xu, Neki V. Patel, Lauren Adams, Balakumar Vijayakrishnan, Philip W. Howard, Marcello Marelli, Herren Wu, Changshou Gao, Javier Read de Alaniz, R. James Christie	21
8	Synthesis and evaluation of pyrrolobenzodiazepine dimer antibody-drug conjugates with dual β-glucuronide and dipeptide triggers 2019 ·European Journal of Medicinal Chemistry ·Stephen J. Gregson, Allison Barrett, Neki V. Patel, (unknown), Davide Schiavone, Erin Sult, Conor S. Barry, Balakumar Vijayakrishnan, Lauren Adams, Luke A. Masterson, François D’Hooge, M. L. Snaith, Jay Harper, John A. Hartley, Philip W. Howard	16
9	Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension 2019 ·Bioconjugate Chemistry ·Qing Li, Allison Barrett, Balakumar Vijayakrishnan, Arnaud Tiberghien, (unknown), Keith Rickert, Kevin Allen, R. James Christie, Marcello Marelli, Jay Harper, Philip W. Howard, Herren Wu, William F. Dall’Acqua, Ping Tsui, Changshou Gao, M. Jack Borrok	19
10	Improved Physical Stability of an Antibody–Drug Conjugate Using Host–Guest Chemistry 2019 ·Bioconjugate Chemistry ·Silvia Sonzini, (unknown), (unknown), Lauren Adams, Luke A. Masterson, Balakumar Vijayakrishnan, Conor S. Barry, (unknown), Peter Ravn, Christopher F. van der Walle	8
11	Evaluation of the non-toxic mutant of the diphtheria toxin K51E/E148K as carrier protein for meningococcal vaccines 2016 ·Vaccine ·Simone Pecetta, Balakumar Vijayakrishnan, Maria Rosaria Romano, Daniela Proietti, Paola Lo Surdo, (unknown), Elena Mori, (unknown), Francesco Berti	3
12	An antibacterial vaccination strategy based on a glycoconjugate containing the core lipopolysaccharide tetrasaccharide Hep2Kdo2 2016 ·Nature Chemistry ·Ling Bing Kong, Balakumar Vijayakrishnan, Michael Kowarik, Jin Park, (unknown), (unknown), Amirreza Faridmoayer, Benjamin G. Davis	52
13	Chain-growth polyglycosylation: synthesis of linker-equipped mannosyl oligomers 2014 ·Carbohydrate Research ·Heiko Schuster, Balakumar Vijayakrishnan, Benjamin G. Davis	12
14	Rationally Designed Short Polyisoprenol-Linked PglB Substrates for Engineered Polypeptide and Protein N-Glycosylation 2013 ·Journal of the American Chemical Society ·Feng Liu, Balakumar Vijayakrishnan, Amirreza Faridmoayer, (unknown), Thomas B. Parsons, Gonçalo J. L. Bernardes, Michael Kowarik, Benjamin G. Davis	39
15	MS of the six isomers of (GlcN)2(GlcNAc)2 aminoglucan tetrasaccharides (diacetylchitotetraoses): Rules of fragmentation for the sodiated molecules and application to sequence analysis of hetero-chitooligosaccharides 2010 ·Carbohydrate Polymers ·Balakumar Vijayakrishnan, (unknown), Yuri Corilo, Christina R. Ferreira, Marcos N. Eberlin, Martin G. Peter	14
16	Analysis of the dispersity in carbohydrate loading of synthetic glycoproteins using MALDI-TOF mass spectrometry 2010 ·Chemical Communications ·Mitul K. Patel, Balakumar Vijayakrishnan, Julia R. Koeppe, Justin M. Chalker, Katie J. Doores, Benjamin G. Davis	23
17	Potent Fluoro‐oligosaccharide Probes of Adhesion in Toxoplasmosis 2009 ·ChemBioChem ·Sarah Allman, Henrik H. Jensen, Balakumar Vijayakrishnan, James A. Garnett, (unknown), Yan Liu, Daniel C. Anthony, Nicola R. Sibson, Ten Feizi, Stephen Matthews, Benjamin G. Davis	60
18	Thiyl Glycosylation of Olefinic Proteins: S‐Linked Glycoconjugate Synthesis 2009 ·Angewandte Chemie International Edition ·(unknown), Balakumar Vijayakrishnan, Julia R. Koeppe, Benjamin G. Davis	190
19	Thiyl Glycosylation of Olefinic Proteins: S‐Linked Glycoconjugate Synthesis 2009 ·Angewandte Chemie ·(unknown), Balakumar Vijayakrishnan, Julia R. Koeppe, Benjamin G. Davis	38
20	A Highly Regio- and Chemoselective Reductive Cleavage of Benzylidene Acetals with EtAlCl₂-Et₃SiH 2004 ·Synlett ·Sundarababu Baskaran, Balakumar Vijayakrishnan, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact